Dublin, Oct. 17, 2022 (GLOBE NEWSWIRE) -- The "Live Cell Imaging Market - Global Outlook & Forecast Market 2022-2027" report has been added to ResearchAndMarkets.com's offering.
Live cell imaging is one of the popular techniques for studying live cells and investigating the biological processes in real-time. It utilizes time-lapse microscopy and careful preparation of living cell environments that have made it easier to observe cell-to-cell interactions and study the behavior of single cells and related changes within the cell. In 2021, North America accounted for the highest share of the global live cell imaging market.
Live cell imaging has revolutionized studying cells, processes, and molecular interactions. Imaging techniques for living cells allow scientists to study cell structures and processes in real-time and over time. Such factors have significantly impacted the growth of the market. A few of the most widespread applications include examining the structural components of a cell, the dynamic studying processes, and the localization of molecules.
Market Trends and Drivers
Rising Target Patient Population
Live cell imaging is a vital tool in the study of cancer biology. Although high-resolution imaging is indispensable for studying genetic and cell signaling changes in underlying cancer, live cell imaging is essential for a deeper understanding of the function and disease mechanisms.
Around 400,000 children develop cancer every year. Developed and emerging countries are facing the burden of communicable diseases. Most developing countries get exposed due to several factors that include demographic, socio-economic, and geographic conditions. Hence, the growing number of deaths and chronic conditions drive the live cell imaging market.
Deep Learning & Artificial Intelligence
The role of Artificial intelligence (AI) in life science is rapidly expanding and holds great potential for microscopy. In the past, the power of microscopy for supporting or disproving scientific hypotheses got limited by scale, and the time associated with quantifying, capturing, and analyzing large numbers of images was often prohibitive. Recently,
AI has made fast inroads into many scientific fields and the world of microscopy. AI-based self-learning microscopy shows the potential to produce high throughput image analysis that is more effortless and less time-consuming. Newer AI technology allows better visualization of unlabeled live cells over a prolonged period.
Increase in Funding for Cell & Gene Therapy
The demand for regenerative medicine has increased across developed countries, and investments in cell & gene therapy have grown drastically in recent years. The public and private sectors are at the forefront of funding cell and gene therapy developers.
Recently, many government organizations and private firms have started funding many biotech start-ups and research institutes that invest in the R&D of cell and gene therapy products. According to the Alliance for Regenerative Medicines, there was a 164% jump in funding for cell & gene therapy in 2019 compared to 2017.
Advancements & Newer Imaging Techniques
Live cell imaging arises from scientific interest coupled with imaging and labeling technology improvements. Putting together various technological advancements with biological interests gives scientists many more ways to use live cell imaging. In particular, exciting progress in probe development has enabled a broad array of nucleic acids, proteins, glycans, lipids, ions, metabolites, and other targets to be labeled. Many recent advancements in microscopic technologies use software that enables a better quantitative image analysis of label-free images.
Also, current microscopy techniques limit the quantity and quality of information available to researchers and clinicians and harm the living cells during long-term studies. Hence new imaging technologies are being developed to overcome various limitations. These advancements will help towards future market growth. For instance, the progress of combining 3D fluorescence imaging and holotomography microscopy has overcome some limitations.
Growing Research-based Activities
In the past two decades, the spending on R&D and the introduction of newer drugs have increased rapidly. In 2019, the pharma industry spent around $83 billion on R&D. From 2010 to 2019, the number of novel drugs were approved, whose sales increased by 60% compared with the previous decade, with a peak of 59 new drugs approved in 2018. The rising amount of R&D expenditure and the number of R&D activities in the pharmaceutical sector has led to the significant growth of the market.
Competitive Landscape
The leading players in the market are implementing various strategies such as marketing and promotional activities, mergers & acquisitions, product launches, and approvals. Also, high R&D investments and boosting distribution networks have helped companies enhance their market share and presence.
The global live cell imaging market includes global and regional players. Major players contributing to the market's significant shares include Agilent, Bruker, Carl Zeiss AG, Danaher, Merck KGaA, PerkinElmer, and Thermo Fisher Scientific. Other prominent players in the market include Axion (CytoSMART Technologies), Bio-Rad Laboratories, blue-ray biotech, Etaluma, Grace Bio Labs, ibidi GmbH, KEYENCE, NanoEnTek, Nanolive SA, Nikon, Olympus, and others.
Key Questions Answered
1. What is the expected live cell imaging market size by 2027?
2. What is the live cell imaging market growth?
3. What are the latest trends in the live cell imaging market?
4. Who are the market leaders in the global live cell imaging market?
5. Which region has the largest live cell imaging market share?
Key Topics Covered:
1 Research Methodology
2 Research Objectives
3 Research Process
4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.1.3 Market Estimation Caveats
4.2 Base Year
4.3 Scope of the Study
4.3.1 Market Segmentation by Product
4.3.2 Market Segmentation by Technique
4.3.3 Market Segmentation by Application
4.3.4 Market Segmentation by End-User
4.3.5 Market Segmentation by Geography
5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
6 Market at a Glance
7 Introduction
7.1 Overview
8 Premium Insights
8.1 Global Live-Cell Imaging Market Scenario
8.1.1 Market Segmentations
8.1.2 Competitive Landscape
8.1.3 Recent Developments in Global Live-Cell Imaging Market
9 Market Opportunities & Trends
9.1 Deep Learning & Artificial Intelligence Enhance Live-Cell Imaging Techniques
9.2 Increased Investments in Cell & Gene Therapy Products
9.3 Tracking Solutions for Live-Cell Imaging
9.4 Advances in Live-Cell Imaging
10 Market Growth Enablers
10.1 Rise in Number of Patients With Cancers & Infectious Diseases
10.2 Adoption of Hcs Methods
10.3 New Techniques in Live-Cell Imaging
10.4 Growth in R&D Activities in Pharmaceutical Industry
11 Market Restraints
11.1 High Cost of Live-Cell Imaging Systems
11.2 Cell Viability & Cellular Environment Maintenance Challenges
11.3 Phototoxicity & Photobleaching in Fluorescence Microscopy
12 Market Landscape
12.1 Market Overview
12.2 Market Size & Forecast
12.2.1 Insights by Product
12.2.2 Insights by Technique
12.2.3 Insights by Application
12.2.4 Insights by End-User
12.2.5 Insights by Geography
12.3 Five Forces Analysis
12.3.1 Threat of New Entrants
12.3.2 Bargaining Power of Suppliers
12.3.3 Bargaining Power of Buyers
12.3.4 Threat of Substitutes
12.3.5 Competitive Rivalry
13 Product
14 Technique
15 Application
16 End-User
17 Geography
18 North America
19 Europe
20 APAC
21 Latin America
22 Middle East & Africa
23 Competitive Landscape
23.1 Competition Overview
23.2 Market Share Analysis
23.2.1 Danaher
23.2.2 Agilent Technologies
23.2.3 Perkinelmer
23.2.4 Merck Kgaa
23.2.5 Zeiss
23.2.6 Thermo Fisher Scientific
24 Key Company Profiles
24.1 Danaher
24.1.1 Business Overview
24.1.2 Danaher in Global Live-Cell Imaging Market
24.1.3 Product Offerings
24.1.4 Key Strategies
24.1.5 Key Strengths
24.1.6 Key Opportunities
24.2 Agilent Technologies
24.2.1 Business Overview
24.2.2 Agilent Technologies in Global Live-Cell Imaging Market
24.2.3 Product Offerings
24.2.4 Key Strategies
24.2.5 Key Strengths
24.2.6 Key Opportunities
24.3 Perkinelmer
24.3.1 Business Overview
24.3.2 Perkinelmer in Global Live-Cell Imaging Market
24.3.3 Product Offerings
24.3.4 Key Strategies
24.3.5 Key Strengths
24.3.6 Key Opportunities
24.4 Merck Kgaa
24.4.1 Business Overview
24.4.2 Merck Kgaa in Global Live-Cell Imaging Market
24.4.3 Product Offerings
24.4.4 Key Strategies
24.4.5 Key Strengths
24.4.6 Key Opportunities
24.5 Zeiss
24.5.1 Business Overview
24.5.2 Zeiss in Global Live-Cell Imaging Market
24.5.3 Product Offerings
24.5.4 Key Strategies
24.5.5 Key Strengths
24.5.6 Key Opportunities
24.6 Thermo Fisher Scientific
24.6.1 Business Overview
24.6.2 Thermo Fisher Scientific in Global Live-Cell Imaging Market
24.6.3 Product Offerings
24.6.4 Key Strategies
24.6.5 Key Strengths
24.6.6 Key Opportunities
25 Other Prominent Vendors
25.1 Axion Biosystems
25.1.1 Business Overview
25.1.2 Product Offerings
25.2 Bd
25.2.1 Business Overview
25.2.2 Product Offerings
25.3 Bio-Rad Laboratories
25.3.1 Business Overview
25.3.2 Product Offerings
25.4 Blue-Ray Biotech
25.4.1 Business Overview
25.4.2 Product Offerings
25.5 Bruker
25.5.1 Business Overview
25.5.2 Product Offerings
25.6 Eppendorf
25.6.1 Business Overview
25.6.2 Product Offerings
25.7 Etaluma
25.7.1 Business Overview
25.7.2 Product Offerings
25.8 Grace Bio-Labs
25.8.1 Business Overview
25.8.2 Product Offerings
25.9 Ibidi GmbH
25.9.1 Business Overview
25.9.2 Product Offerings
25.10 Intelligent Imaging Innovations
25.10.1 Business Overview
25.10.2 Product Offerings
25.11 Keyence Corporation
25.11.1 Business Overview
25.11.2 Product Offerings
25.12 Logos Biosystems
25.12.1 Business Overview
25.12.2 Product Offerings
25.13 Nanoentek
25.13.1 Business Overview
25.13.2 Product Offerings
25.14 Nanolive Sa
25.14.1 Business Overview
25.14.2 Product Offerings
25.15 Nikon
25.15.1 Business Overview
25.15.2 Product Offerings
25.16 Evident
25.16.1 Business Overview
25.16.2 Product Offerings
25.17 Oni
25.17.1 Business Overview
25.17.2 Product Offerings
25.18 Oxford Instruments
25.18.1 Business Overview
25.18.2 Product Offerings
25.19 Phase Focus
25.19.1 Business Overview
25.19.2 Product Offerings
25.20 Phase Holographic Imaging Phi Ab
25.20.1 Business Overview
25.20.2 Product Offerings
25.21 Proteintech Group
25.21.1 Business Overview
25.21.2 Product Offerings
25.22 Sartorius AG
25.22.1 Business Overview
25.22.2 Product Offerings
25.23 Sony Biotechnology
25.23.1 Business Overview
25.23.2 Product Offerings
25.24 Tomocube
25.24.1 Business Overview
25.24.2 Product Offerings
26 Report Summary
26.1 Key Takeaways
26.2 Strategic Recommendations
27 Quantitative Summary
28 Appendix
For more information about this report visit https://www.researchandmarkets.com/r/yzv3ai
